Tissot A C, Pecorari F, Plückthun A
Biochemisches Institut, Universität Zürich, Winterthurstrasse 190, CH-8057, Zürich, Switzerland.
J Immunol Methods. 2000 Mar 6;236(1-2):147-65. doi: 10.1016/s0022-1759(99)00226-4.
The very low affinity of the T-cell receptor (TCR) for the peptide-major histocompatibility complex (pMHC) has made it very challenging to design assays for testing the functionality of these molecules on small scales, which in turn has severely hampered the progress in developing expression and refolding methodologies for the TCR. We have now developed an ELISA assay for detecting pMHC binding to functional recombinant TCRs. It uses tetramers of biotinylated pMHCs bound to a neutravidin-horseradish peroxidase conjugate and detects the presence of functional TCR, bound in a productive orientation to an immobilized anti-Cbeta antibody. Specificity can be stringently demonstrated by inhibition with monomeric pMHCs. The assay is very sensitive and specific, and requires only very small amounts of protein. It has allowed us to study the unstable recombinant TCR P14, which we expressed and refolded from Escherichia coli. The TCR P14 is directed against the most abundant epitope of LCMV. We have confirmed the specificity of the interaction by BIAcore, and were able to determine the dissociation constant of the interaction of the P14 TCR and of the gp33-pMHC as 6 microM. This affinity ranks it among the tighter ones of TCR-pMHC interactions, and unusually low affinity thus does not seem to be the cause of the modest protective power of these T-cells, compared to others elicited in the anti-LCMV response. This strategy of multimerizing one partner and immobilizing the other in both a native form and productive orientation should be generally useful for characterizing the weak interactions of cell-surface molecules.
T细胞受体(TCR)对肽-主要组织相容性复合体(pMHC)的亲和力极低,这使得设计小规模检测这些分子功能的检测方法极具挑战性,进而严重阻碍了TCR表达和重折叠方法的发展进程。我们现已开发出一种酶联免疫吸附测定(ELISA)法,用于检测pMHC与功能性重组TCR的结合。该方法使用与中性抗生物素蛋白-辣根过氧化物酶偶联物结合的生物素化pMHC四聚体,并检测以有效方向与固定化抗Cβ抗体结合的功能性TCR的存在。通过用单体pMHC进行抑制可严格证明其特异性。该检测方法非常灵敏且特异,仅需极少量的蛋白质。它使我们能够研究不稳定的重组TCR P14,我们从大肠杆菌中表达并重折叠了该TCR。TCR P14针对淋巴细胞脉络丛脑膜炎病毒(LCMV)最丰富的表位。我们已通过表面等离子体共振(BIAcore)确认了相互作用的特异性,并能够确定P14 TCR与gp33-pMHC相互作用的解离常数为6微摩尔。这种亲和力使其成为TCR-pMHC相互作用中亲和力较强的之一,因此与抗LCMV反应中引发的其他T细胞相比,异常低的亲和力似乎并非这些T细胞保护能力适中的原因。将一个伙伴多聚化并以天然形式和有效方向固定另一个伙伴的这种策略通常应有助于表征细胞表面分子的弱相互作用。